Details for New Drug Application (NDA): 018166

✉ Email this page to a colleague

NDA 018166 describes TRASICOR, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the TRASICOR profile page.

The generic ingredient in TRASICOR is oxprenolol hydrochloride. There is one drug master file entry for this compound. Additional details are available on the oxprenolol hydrochloride profile page.

Summary for 018166

Tradename:	TRASICOR
Applicant:	Novartis
Ingredient:	oxprenolol hydrochloride
Patents:	0

Medical Subject Heading (MeSH) Categories for 018166

Adrenergic beta-Antagonists
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Antihypertensive Agents
Sympatholytics
Vasodilator Agents

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	CAPSULE;ORAL			Strength	20MG
Approval Date:	Dec 28, 1983	TE:		RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	CAPSULE;ORAL			Strength	40MG
Approval Date:	Dec 28, 1983	TE:		RLD:	No

Profile for product number 003

Active Rx/OTC/Discontinued:	DISCN	Dosage:	CAPSULE;ORAL			Strength	80MG
Approval Date:	Dec 28, 1983	TE:		RLD:	No

Expired US Patents for NDA 018166

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis	TRASICOR	oxprenolol hydrochloride	CAPSULE;ORAL	018166-002	Dec 28, 1983	⤷ Start Trial	⤷ Start Trial
Novartis	TRASICOR	oxprenolol hydrochloride	CAPSULE;ORAL	018166-003	Dec 28, 1983	⤷ Start Trial	⤷ Start Trial
Novartis	TRASICOR	oxprenolol hydrochloride	CAPSULE;ORAL	018166-004	Dec 28, 1983	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.